Budget impact analysis of Intravenous Magnesium Sulfate for Treating
Asthma Exacerbations in Children
- Diana Guerrer,
- Jefferson Buendia
Abstract
Intravenous Magnesium SulfateIV was cost-saving in emergency settings
for treating children with asthma exacerbations. This shift in treatment
approach proved to be economically favorable, reducing the cost of
hospitalization and mechanical ventilation21 Nov 2020Submitted to Pediatric Pulmonology 26 Nov 2020Submission Checks Completed
26 Nov 2020Assigned to Editor
10 Dec 2020Reviewer(s) Assigned
24 Dec 2020Review(s) Completed, Editorial Evaluation Pending
04 Jan 2021Editorial Decision: Revise Minor
08 Jan 20211st Revision Received
08 Jan 2021Submission Checks Completed
08 Jan 2021Assigned to Editor
08 Jan 2021Reviewer(s) Assigned
01 Mar 2021Review(s) Completed, Editorial Evaluation Pending
06 Mar 2021Editorial Decision: Accept
